Want to join the conversation?
$CLX's 2020 strategy, which was introduced in FY14, focuses on delivering long-term, profitable growth and strong stockholder returns. $CLX's long-term financial goals include annual net sales growth of 3-5%, market share growth, annual EBIT margin growth of 25-50 basis points and annual free cash flow as a percentage of net sales of about 10-12%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)